175 related articles for article (PubMed ID: 35861038)
21. Pirfenidone exhibits cardioprotective effects by regulating myocardial fibrosis and vascular permeability in pressure-overloaded hearts.
Yamagami K; Oka T; Wang Q; Ishizu T; Lee JK; Miwa K; Akazawa H; Naito AT; Sakata Y; Komuro I
Am J Physiol Heart Circ Physiol; 2015 Aug; 309(3):H512-22. PubMed ID: 26055790
[TBL] [Abstract][Full Text] [Related]
22. ADAMTS16 activates latent TGF-β, accentuating fibrosis and dysfunction of the pressure-overloaded heart.
Yao Y; Hu C; Song Q; Li Y; Da X; Yu Y; Li H; Clark IM; Chen Q; Wang QK
Cardiovasc Res; 2020 Apr; 116(5):956-969. PubMed ID: 31297506
[TBL] [Abstract][Full Text] [Related]
23. Belumosudil, ROCK2-specific inhibitor, alleviates cardiac fibrosis by inhibiting cardiac fibroblasts activation.
Liu Q; Li HY; Wang SJ; Huang SQ; Yue Y; Maihemuti A; Zhang Y; Huang L; Luo L; Feng KN; Wu ZK
Am J Physiol Heart Circ Physiol; 2022 Jul; 323(1):H235-H247. PubMed ID: 35657612
[TBL] [Abstract][Full Text] [Related]
24. Cardiac Contractility Modulation Attenuate Myocardial Fibrosis by Inhibiting TGF-β1/Smad3 Signaling Pathway in a Rabbit Model of Chronic Heart Failure.
Zhang F; Dang Y; Li Y; Hao Q; Li R; Qi X
Cell Physiol Biochem; 2016; 39(1):294-302. PubMed ID: 27344462
[TBL] [Abstract][Full Text] [Related]
25. Acetazolamide attenuates cardiac fibrosis induced by aortic constriction through inhibiting transforming growth factor-β1/Smad2 signaling pathway in mice.
Huo Q; Wang T; Wang T; Zhang R
Exp Ther Med; 2019 Mar; 17(3):2317-2321. PubMed ID: 30867716
[TBL] [Abstract][Full Text] [Related]
26. Aminoacylase-1 plays a key role in myocardial fibrosis and the therapeutic effects of 20(S)-ginsenoside Rg3 in mouse heart failure.
Lai Q; Liu FM; Rao WL; Yuan GY; Fan ZY; Zhang L; Fu F; Kou JP; Yu BY; Li F
Acta Pharmacol Sin; 2022 Aug; 43(8):2003-2015. PubMed ID: 34916608
[TBL] [Abstract][Full Text] [Related]
27. Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction.
Han A; Lu Y; Zheng Q; Zhang J; Zhao Y; Zhao M; Cui X
Cell Physiol Biochem; 2018; 45(5):1797-1806. PubMed ID: 29510381
[TBL] [Abstract][Full Text] [Related]
28. The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice.
Yamazaki T; Yamashita N; Izumi Y; Nakamura Y; Shiota M; Hanatani A; Shimada K; Muro T; Iwao H; Yoshiyama M
Hypertens Res; 2012 Jan; 35(1):34-40. PubMed ID: 21866107
[TBL] [Abstract][Full Text] [Related]
29. Suppression of TGF-β1/Smad signaling pathway by sesamin contributes to the attenuation of myocardial fibrosis in spontaneously hypertensive rats.
Zhao M; Zheng S; Yang J; Wu Y; Ren Y; Kong X; Li W; Xuan J
PLoS One; 2015; 10(3):e0121312. PubMed ID: 25793583
[TBL] [Abstract][Full Text] [Related]
30. Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren's disease -derived fibroblasts.
Zhou C; Zeldin Y; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2019 Mar; 20(1):135. PubMed ID: 30927912
[TBL] [Abstract][Full Text] [Related]
31. CTRP15 derived from cardiac myocytes attenuates TGFβ1-induced fibrotic response in cardiac fibroblasts.
Zhao Q; Zhang CL; Xiang RL; Wu LL; Li L
Cardiovasc Drugs Ther; 2020 Oct; 34(5):591-604. PubMed ID: 32424654
[TBL] [Abstract][Full Text] [Related]
32. Qindan Capsule Attenuates Myocardial Hypertrophy and Fibrosis in Pressure Overload-Induced Mice Involving mTOR and TGF-
Bai W; Ren M; Cheng W; Lu X; Liu D; Wang B
Evid Based Complement Alternat Med; 2021; 2021():5577875. PubMed ID: 34007292
[TBL] [Abstract][Full Text] [Related]
33. Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2/3 transactivation.
Bugyei-Twum A; Ford C; Civitarese R; Seegobin J; Advani SL; Desjardins JF; Kabir G; Zhang Y; Mitchell M; Switzer J; Thai K; Shen V; Abadeh A; Singh KK; Billia F; Advani A; Gilbert RE; Connelly KA
Cardiovasc Res; 2018 Oct; 114(12):1629-1641. PubMed ID: 29800064
[TBL] [Abstract][Full Text] [Related]
34. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
[TBL] [Abstract][Full Text] [Related]
35. Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1-Endothelin-1 Signal Pathway.
Liu J; Zhuang T; Pi J; Chen X; Zhang Q; Li Y; Wang H; Shen Y; Tomlinson B; Chan P; Yu Z; Cheng Y; Zheng X; Reilly M; Morrisey E; Zhang L; Liu Z; Zhang Y
Circulation; 2019 Aug; 140(8):665-680. PubMed ID: 31177814
[TBL] [Abstract][Full Text] [Related]
36. Specific α7 nicotinic acetylcholine receptor agonist ameliorates isoproterenol-induced cardiac remodelling in mice through TGF-β1/Smad3 pathway.
Yang YH; Fang HL; Zhao M; Wei XL; Zhang N; Wang S; Lu Y; Yu XJ; Sun L; He X; Li DL; Liu JJ; Zang WJ
Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1192-1200. PubMed ID: 28732106
[TBL] [Abstract][Full Text] [Related]
37. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
38. Qingda granule attenuates cardiac fibrosis via suppression of the TGF-β1/Smad2/3 signaling pathway in vitro and in vivo.
Chen X; Long L; Cheng Y; Chu J; Shen Z; Liu L; Li J; Xie Q; Liu H; Wu M; Chen Y; Peng J; Shen A
Biomed Pharmacother; 2021 May; 137():111318. PubMed ID: 33556875
[TBL] [Abstract][Full Text] [Related]
39. Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer.
Fujiwara A; Shintani Y; Funaki S; Kawamura T; Kimura T; Minami M; Okumura M
Lung Cancer; 2017 Apr; 106():8-16. PubMed ID: 28285699
[TBL] [Abstract][Full Text] [Related]
40. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
